These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 8803908

  • 1. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI, Dixon R, Guarrasi V, Krubel S.
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [Abstract] [Full Text] [Related]

  • 2. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M, Ulbricht K, Schmidt RE, Witte T.
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P.
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [Abstract] [Full Text] [Related]

  • 4. Antimalarials in Sjögren's syndrome--the Greek experience.
    Manoussakis MN, Moutsopoulos HM.
    Lupus; 1996 Jun; 5 Suppl 1():S28-30. PubMed ID: 8803907
    [Abstract] [Full Text] [Related]

  • 5. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [Abstract] [Full Text] [Related]

  • 6. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J.
    Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
    [Abstract] [Full Text] [Related]

  • 8. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
    Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O.
    Arthritis Res Ther; 2006 Apr; 8(4):R129. PubMed ID: 16859536
    [Abstract] [Full Text] [Related]

  • 9. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [Abstract] [Full Text] [Related]

  • 10. Treatment of primary Sjögren's syndrome with D-penicillamine: a pilot study.
    ter Borg EJ, Haanen HC, Haas FJ, Bistervels JH, Huisman FW, Kerckhaert JA, Kallenberg CG.
    Neth J Med; 2002 Nov; 60(10):402-6. PubMed ID: 12607591
    [Abstract] [Full Text] [Related]

  • 11. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [Abstract] [Full Text] [Related]

  • 12. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
    Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M, Ligier S, Radfar L, Kok MR, Kingman A, Fox PC.
    Arthritis Rheum; 2004 Aug 15; 51(4):601-4. PubMed ID: 15334433
    [Abstract] [Full Text] [Related]

  • 13. Sjögren's syndrome. Controversies and progress.
    Fox RI.
    Clin Lab Med; 1997 Sep 15; 17(3):431-44. PubMed ID: 9316767
    [Abstract] [Full Text] [Related]

  • 14. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB.
    Retina; 2008 Sep 15; 28(10):1478-86. PubMed ID: 18997610
    [Abstract] [Full Text] [Related]

  • 15. Management of patients presenting with Sjogren's syndrome.
    Venables PJ.
    Best Pract Res Clin Rheumatol; 2006 Aug 15; 20(4):791-807. PubMed ID: 16979538
    [Abstract] [Full Text] [Related]

  • 16. [Salivary immunoglobulins in the diagnosis of primary Sjögren's syndrome].
    Bianucci GF, Campana G, Maddali Bongi S, Palermo C, Castagnoli A.
    Minerva Med; 1993 Apr 15; 84(4):161-70. PubMed ID: 8506054
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.
    Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S.
    Ann Rheum Dis; 2015 Mar 15; 74(3):526-31. PubMed ID: 24347569
    [Abstract] [Full Text] [Related]

  • 18. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
    Vissink A, Kalk WW, Mansour K, Spijkervet FK, Bootsma H, Roodenburg JL, Kallenberg CG, Nieuw Amerongen AV.
    Arch Otolaryngol Head Neck Surg; 2003 Sep 15; 129(9):966-71. PubMed ID: 12975269
    [Abstract] [Full Text] [Related]

  • 19. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B, Chew JB, White VA, Garcia-Briones G, Chhanabhai M, Rootman J.
    Ophthalmology; 2005 Nov 15; 112(11):2040-7. PubMed ID: 16168486
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and characteristics of Sjögren's syndrome or Sicca syndrome in chronic hepatitis C virus infection: a prospective study.
    Loustaud-Ratti V, Riche A, Liozon E, Labrousse F, Soria P, Rogez S, Babany G, Delaire L, Denis F, Vidal E.
    J Rheumatol; 2001 Oct 15; 28(10):2245-51. PubMed ID: 11669164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.